<DOC>
	<DOC>NCT00492960</DOC>
	<brief_summary>This study will look at 3 doses of AT1001 for efficacy and safety for the treatment of celiac disease. The primary efficacy outcome is to evaluate the efficacy of multiple dose levels of AT-1001 in preventing intestinal permeability changes induced by a 6- week gluten challenge.</brief_summary>
	<brief_title>Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease</brief_title>
	<detailed_description>This is an outpatient, randomized, double blind multicenter study. Subjects will remain on their gluten-free diet throughout the duration of the trial. Study drug or drug placebo capsules will be administered TID 15 minutes before each meal (breakfast, lunch, and dinner). Gluten or gluten placebo capsules will be taken TID with each meal.</detailed_description>
	<mesh_term>Celiac Disease</mesh_term>
	<criteria>Eligible subjects must meet all of the following criteria before being enrolled into the study: 1. Age between 18 and 72 years, inclusive. 2. Diagnosed with celiac disease for more than 6 months. 3. AntiTissue Transglutaminase (antitTG) less than 10 EU. 4. On a glutenfree diet for at least 6 months. 5. BMI between 18.5 and 38, inclusive. Exclusion Criteria Subjects meeting any one of the following criteria are not eligible for the study: 1. Current smoker. 2. Has chronic active GI disease other than celiac disease (e.g. Crohn's, Colitis). 3. Has diabetes (Type 1 or Type 2). 4. Unable to abstain from alcohol consumption for 48 hours prior to each intestinal permeability collection throughout the study. 5. Unable to refrain from consuming nonsteroidal antiinflammatory agents, including aspirin ("NSAIDs") for 48 hours prior to each intestinal permeability collection throughout the study. 6. Participated in any clinical drug study within the past 30 days or has had previous exposure to AT1001. 7. Presents with or has a history of dermatitis herpetiformis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Celiac Disease</keyword>
</DOC>